Alma Lasers BeautiFill
Laser lipolysis (internal) · 1470nm laser lipo + fat transfer
What it's actually cleared for: Cleared as Alma LipoFlow System (July 2017) — laser lipoplasty; BeautiFill marketed under it; fat-transfer component BK220713
Last verified: August 6, 2026 · How we verify
New: $150k–$200k|Used: $60k–$100kmarket estimate, no email required
Bottom line
The niche play: a 1470nm laser-lipolysis platform whose real selling point is closed-loop fat harvesting and transfer — lipo, graft processing, and reinjection in one sterile circuit. For a natural-fat-augmentation practice (facial grafting, hands, small-volume body transfer) it's the most purpose-built system on the market. But it's a single-purpose story from a company with a thin US surgical footprint, the used market is shallow, and most surgeons get comparable grafting results from VASER or syringe systems at lower cost.
Overview
Laser harvesting for fat grafting
How it works
The science
Based on Alma's LipoLife platform — a 1470nm diode laser fires radially from a fiber inside the aspiration cannula, simultaneously loosening fat and coagulating tissue while low-vacuum suction draws fat into a closed sterile collection system. The wavelength targets water and fat with shallow penetration, so energy exposure of harvested fat is brief — Alma's core claim is high adipocyte viability (~95% in company-cited work). Harvested fat is filtered and transferred without leaving the closed circuit, cutting contamination risk and OR time, then reinjected for facial, hand, breast, or buttock volume.
Patented tech
The LipoLife radial-emission fiber-in-cannula design plus closed-loop harvesting/transfer circuit; companion LipoFlow automates wash/filter/transfer.
Origin
Alma Lasers Ltd., Caesarea, Israel (Sisram/Fosun Pharma); US distribution via Alma Inc., Buffalo Grove, Illinois.
FDA & regulatory status
What it's actually cleared for:
Cleared as Alma LipoFlow System (July 2017) — laser lipoplasty; BeautiFill marketed under it; fat-transfer component BK220713
510(k) numbers
K171242
Regulatory data is compiled from public FDA 510(k) records and may lag recent clearances. Always confirm status with the manufacturer before purchase.
Treatment economics
What practices charge
Combined lipo-plus-fat-transfer: ~$6,000-12,000 facial fat transfer with donor-site lipo; $10,000-20,000+ body transfer cases; standalone laser lipo of a small area $3,500-7,000.
Consumables & recurring cost
Sterile closed-loop kits (cannula/fiber assemblies, canisters, transfer sets) ~$300-700 per case through Alma — verify; annual spend scales with case volume.
Ideal for
Best-fit practice
Facial plastic, plastic, and cosmetic surgeons whose brand is natural volume restoration and regenerative aesthetics — surgeon-owned, not a delegated medspa service. Patients: 40s-60s facial volume-loss patients rejecting filler maintenance.
Compliance
Medical director & delegation
Laser lipolysis and autologous fat grafting are surgery — physician-performed; fat handling also implicates FDA HCT/P same-surgical-procedure requirements, so keep everything in one session.
Contraindications & screening
Pregnancy, coagulopathy, active infection, significant comorbidities, unrealistic volume expectations; caution in smokers (graft take) and large-volume debulking cases.
Ownership
Warranty & service
~12-month Alma warranty; Alma's US service is solid on energy devices but the surgical install base is small — confirm local field coverage before signing.
Resale & used market
Shallow, illiquid — few units in circulation, listings sit; expect steep depreciation (~$30k-60k used) and plan to hold to end of life.
Chains using this device
No confirmed chain deployments recorded yet.
Owner reviews
Write a reviewNo approved reviews yet. Be the first owner to publish one.
Alternatives
History
Every tracked change to pricing, lifecycle status, FDA data and warranty terms — newest first.
August 5, 2026
FDA K-numbers
K171242
Source: Automatic record update
August 5, 2026
FDA status
Unknown → Cleared
Source: Automatic record update
August 5, 2026
FDA indication
The LipoFlow fat-transfer component holds a verifiable substantially-equivalent clearance (BK220713, via FDA/CBER); the BeautiFill 1470nm laser-lipolysis platform is marketed as FDA-cleared for laser-assisted lipolysis and fat grafting — verify the specific K-number on accessdata.fda.gov before publishing. → Cleared as Alma LipoFlow System (July 2017) — laser lipoplasty; BeautiFill marketed under it; fat-transfer component BK220713
Source: Automatic record update
August 1, 2026
Record created
Added to The Aesthetic Index — August 2026
Source: The Aesthetic Index editorial
Get the full State of Aesthetic Devices 2026 report
The first independent census of the US aesthetic device market — free.